A joint modeling approach for analyzing marker data in the presence of a terminal event

In many medical studies, markers are contingent on recurrent events and the cumulative markers are usually of interest. However, the recurrent event process is often interrupted by a dependent terminal event, such as death. In this article, we propose a joint modeling approach for analyzing marker data with informative recurrent and terminal events. This approach introduces a shared frailty to specify the explicit dependence structure among the markers, the recurrent, and terminal events. Estimation procedures are developed for the model parameters and the degree of dependence, and a prediction of the covariate-specific cumulative markers is provided. The finite sample performance of the proposed estimators is examined through simulation studies. An application to a medical cost study of chronic heart failure patients from the University of Virginia Health System is illustrated.

Double robust estimator of average causal treatment effect for censored medical cost data

In observational studies, estimation of average causal treatment effect on a patient's response should adjust for confounders that are associated with both treatment exposure and response. In addition, the response, such as medical cost, may have incomplete follow-up. In this article, a double robust estimator is proposed for average causal treatment effect for right censored medical cost data. The estimator is double robust in the sense that it remains consistent when either the model for the treatment assignment or the regression model for the response is correctly specified. Double robust estimators increase the likelihood the results will represent a valid inference. Asymptotic normality is obtained for the proposed estimator, and an estimator for the asymptotic variance is also derived. Simulation studies show good finite sample performance of the proposed estimator and a real data analysis using the proposed method is provided as illustration. Copyright © 2016 John Wiley & Sons, Ltd.

Nonparametric inference for median costs with censored data

Increasingly, estimations of health care costs are used to evaluate competing treatments or to assess the expected expenditures associated with certain diseases. In health policy and economics, the primary focus of these estimations has been on the mean cost, because the total cost can be derived directly from the mean cost, and because information about total resources utilized is highly relevant for policymakers. Yet, the median cost also could be important, both as an intuitive measure of central tendency in cost distribution and as a subject of interest to payers and consumers. In many prospective studies, cost data collection is sometimes incomplete for some subjects due to right censoring, which typically is caused by loss to follow-up or by limited study duration. Censoring poses a unique challenge for cost data analysis because of so-called induced informative censoring, in that traditional methods suited for survival data generally are invalid in censored cost estimation. In this article, we propose methods for estimating the median cost and its confidence interval (CI) when data are subject to right censoring. We also consider the estimation of the ratio and difference of two median costs and their CIs. These methods can be extended to the estimation of other quantiles and other informatively censored data. We conduct simulation and real data analysis in order to examine the performance of the proposed methods.